CN108445220A - A kind of H-FABP and cTnI bigeminy efficient detection test paper - Google Patents
A kind of H-FABP and cTnI bigeminy efficient detection test paper Download PDFInfo
- Publication number
- CN108445220A CN108445220A CN201810225535.7A CN201810225535A CN108445220A CN 108445220 A CN108445220 A CN 108445220A CN 201810225535 A CN201810225535 A CN 201810225535A CN 108445220 A CN108445220 A CN 108445220A
- Authority
- CN
- China
- Prior art keywords
- antibody
- gold
- pad
- fabp
- ctni
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The invention discloses a kind of H FABP and cTnI bigeminy efficient detection test paper, it is characterised in that：Including being located at the sample pad being sequentially connected in fixed plate (1), gold-labelled pad (2), nitrocellulose filter (3) and absorption pad (4)；Detection line antibody (5) and nature controlling line antibody (6) are equipped on nitrocellulose filter (3)；Gold labeling antibody is equipped in gold-labelled pad (2), the sample pad (1) is pad made of glass fibre cotton, the gold-labelled pad (2) is pad made of carboxylated cellulose film, the gold labeling antibody is colour developing antibody, detection line antibody is to capture antibody, colour developing antibody can mutually match to form sandwich anti-human H FABP monoclonal antibodies with antibody is captured for 2 plants, and the gold labeling antibody is marked with 40nm nanometers of golden shells, and the gold-labelled pad is equipped with functional layer.The present invention enables to avoid interfering with each other between sample when detection, can greatly improve accuracy of detection by the gold-labelled pad and soaking technology of particular functional layer.
Description
Technical field
The invention belongs to biological technology applications, and in particular to a kind of cardic fatty acid binding protein H-FABP
(Heart-typeFattyAcidBindingProtein, H-FABP) and cTnI (cardiactroponinI,
CTnI) cTnI bigeminy efficient detection test paper.
Background technology
H-FABP is present in myocardial cell cytoplasm, rich content.Myocardial damage early stage, cardiac muscle cell's film integrality are broken
Bad, H-FABP enters blood.H-FABP 1-2h after myocardial damage can be detected in blood.Since H-FABP cardiac muscles are special
Property higher than current clinically used myoglobins, therefore H-FABP can become a kind of important detection Acute myocardial tissue damage
Earlier specificity marker.Currently, the detection of biochemical marker is widely used to acute myocardial infarction AMI, the instability mode heart twists
Bitterly, the diagnosis of the myocardial injury diseases such as acute heart failure, myocarditis, openheart surgery lesion assessment, Newborns with Asphyxia myocardial damage, danger
Dangerous degree layering and prognosis are judged.The U.S. every year because suspect property coronary syndrome emergency treatment medical treatment patient up to 80,000,000, wherein
45% or so is related to heart, and 15% is diagnosed as acute coronary syndrome.The incidence of China's acute coronary syndrome is about
50/100000, the number for dying of acute myocardial infarction AMI every year is more than 1,000,000.Therefore, the application of H-FABP detections has important society
Meeting and economic benefit.
When cardiac muscle cells go to pot because of factors such as hypoxic-ischemics, sequestered cTnI and cTnT can be first rapidly from cells
It is released into blood, is gradually decomposed later in conjunction with the mating type cTnI and cTnT in myocardial structural albumen, is slowly released into circulating
In, to explain with the disease that myocardial cell damage is performance, such as acute myocardial infarction AMI (AMI), cTnI and cTnT are being recycled
It is relatively early in blood the reason of simultaneously energy last longer occur.
So H-FABP and cTnI is very important health index parameters for myocardium health.The prior art cannot
Two kinds of substances of efficient detection simultaneously, substance interferes with each other when detection, instead reduces the detection sensitivity of gold-labelled pad.
Invention content
Goal of the invention：For the deficiencies in the prior art, the object of the present invention is to provide a kind of H-FABP and cTnI
Bigeminy efficient detection test paper, make it have easy to operate, sensitivity ＜ 5ng/mL, result stablize the advantages that.
Invention content：The present invention provides a kind of H-FABP and cTnI bigeminy efficient detection test paper, including are located at fixed plate
On the sample pad (1), gold-labelled pad (2), nitrocellulose filter (3) and the absorption pad (4) that are sequentially connected；In nitrocellulose filter (3)
It is equipped with detection line antibody (5) and nature controlling line antibody (6)；Gold labeling antibody, the sample pad (1) are equipped in gold-labelled pad (2)
To be padded made of glass fibre cotton, the gold-labelled pad (2) is pad made of carboxylated cellulose film, and the gold labeling antibody is aobvious
Color antibody, detection line antibody are to capture antibody, and colour developing antibody is 3 plants with capture antibody can mutually match to form sandwich anti-human H-
Gold labeling antibody described in FABP and cTnI monoclonal antibodies is marked with 40nm nanometers of golden shells, and the gold-labelled pad is equipped with functional layer,
The gold-labelled pad passes through sodium bicarbonate, bovine serum albumin(BSA), casein and polyoxy alkene bay ether mixed liquid dipping.
Further, the functional layer based on mass fraction by 18% pure silver nitrate, 70% gelatin, 8% department's sheet 80 with
And 4% cyclodextrin forms.
Further, the gold-labelled pad by 80% sodium bicarbonate solution, 8% bovine serum albumin(BSA), 8% casein and
4% polyoxy alkene bay ether mixed liquid dipping.
The preparation method of above-mentioned H-FABP and cTnI bigeminy efficient detection test paper, includes the following steps：
(1) it uses using trisodium citrate as stabilizer and reducing agent, prepares monodispersed silver nano-grain as sacrifice
Template, by the 40nm gold nanoshells for replacing reaction acquisition colloid, high dispersive；
(2) nanogold shell solution pH8.0~8.5 are adjusted, colour developing antibody is added and is reacted with nanogold shell solution, centrifuges heavy
It forms sediment, precipitation is resuspended, obtains gold labeling antibody solution；
(3) after carboxylated cellulose film being pre-processed, drying, by that will be matched respectively by infrared spraying equipment in vacuum environment
18% pure silver nitrate, 70% macromolecule dispersant, 8% department's sheet 80 and 4% cyclodextrin made is sprayed into carboxylation fiber
Plain film forms well gold-labelled pad, then uses gold labeling antibody solution spray printing；
(4) immersion of gold-labelled pad：Gold-labelled pad by 80% sodium bicarbonate solution, 8% bovine serum albumin(BSA), 8% casein with
And 4% polyoxy alkene bay ether mixed liquid dipping, then dry.
(5) it is sprayed on having activated nitrocellulose filter with capture antibody and draws a detection line, vacuum drying；Then sheep anti mouse is used
IgG sprays on having activated nitrocellulose membrane draws nature controlling line, vacuum drying；
(6) it is pasted onto on the plastic plate of single side pressure sensitive adhesive, cuts by sample pad, gold-labelled pad, nitrocellulose membrane, absorption pad sequence
It cuts, is packed into plastic clip, packaging.
Advantageous effect：H-FABP the and cTnI bigeminy efficient detection test paper of the present invention, contains specific function by special
The gold-labelled pad and soaking technology of layer so that gold mark rate of release slows down, and is buffered, to make analyte in sample be marked with gold
The concentration proportion of antibody increases, to improve the sensitivity of ELISA test strip.
In addition, by the gold-labelled pad and soaking technology of particular functional layer, enable to avoid mutually between sample when detection
Interference, can greatly improve accuracy of detection.
Description of the drawings
Fig. 1 is the structural schematic diagram of test strips.
Specific implementation mode
With reference to specific embodiment, the present invention is described further.
As shown in Figure 1, a kind of H-FABP and cTnI bigeminy efficient detection test paper, including it is located at and is sequentially connected in fixed plate
Sample pad (1), gold-labelled pad (2), nitrocellulose filter (3) and absorption pad (4)；Detection line is equipped on nitrocellulose filter (3)
Antibody (5) and nature controlling line antibody (6)；Gold labeling antibody is equipped in gold-labelled pad (2), the sample pad (1) is glass fibre cotton
Manufactured pad, the gold-labelled pad (2) are pad made of carboxylated cellulose film, and the gold labeling antibody is colour developing antibody, detection
Line antibody is to capture antibody, and colour developing antibody is 3 plants with capture antibody can mutually match to form sandwich anti-human H-FABP and cTnI
Gold labeling antibody described in monoclonal antibody is marked with 40nm nanometers of golden shells, and the gold-labelled pad is equipped with functional layer, the gold-labelled pad
Pass through sodium bicarbonate, bovine serum albumin(BSA), casein and polyoxy alkene bay ether mixed liquid dipping.The functional layer is with quality point
Several meters are made of 18% pure silver nitrate, 70% gelatin, 8% department's sheet 80 and 4% cyclodextrin, and the gold-labelled pad is by 80% carbon
Sour hydrogen sodium solution, 8% bovine serum albumin(BSA), 8% casein and 4% polyoxy alkene bay ether mixed liquid dipping.
The preparation method of above-mentioned test paper is as follows：
(1) preparation of nanogold shell solution：
Using trisodium citrate as stabilizer and reducing agent, prepares monodispersed silver nano-grain and be used as " seed "：At 70 DEG C
Water-bath under 80mL deionized waters are heated to constant temperature, the citric acid three sodium solution of 20mL1% (wt) is added, stirs evenly, adds
Enter the AgNO of 1.7mL10mg/mL3Solution is vigorously stirred lower addition 2mL 1%NaHB4Solution, then continuous heating and stirring 1h,
It is settled to 100mL after room temperature cooling.
" seed " of silver nano-grain is grown：1% sodium citrate solutions of 2mL are added into 80mL deionized waters and heat
To fluidized state, the silver-colored seed solution that certain volume is then added is added 1.7mL10mg/mL's in being vigorously stirred process
AgNO3Solution continues to keep stirring and heat 30min, and constant volume is to 100mL after room temperature cooling.
It is to sacrifice template with silver nano-grain, colloid, high monodispersed gold nanoshell is prepared by replacing reaction：It takes
30mL silver nanoparticle solutions centrifuge 20min at 12500g, pour out supernatant, then with deionized water constant volume to 100mL.It will
The silver nanoparticle solution of this 100mL is heated to fluidized state, and 2mM HAuCl are added with vigorous stirring4Solution 2mL, reaction
Liquid color is gradually changed into blackish green, room temperature cooling by yellow.
(2) the gold label of colour developing antibody：
Nanogold shell solution pH8.0~8.5 are adjusted, colour developing antibody is added and is reacted with nanogold shell solution, centrifuges to obtain precipitation,
Precipitation is resuspended, obtains gold labeling antibody solution.
(3) prepared by gold-labelled pad and spray is padded：
After carboxylated cellulose film is pre-processed, drying, by that will be prepared respectively by infrared spraying equipment in vacuum environment
18% pure silver nitrate, 70% macromolecule dispersant, 8% department's sheet 80 and 4% cyclodextrin got well are sprayed into carboxylated cellulose
Film forms well gold-labelled pad, then uses gold labeling antibody solution spray printing.
(4) immersion of gold-labelled pad：Gold-labelled pad by 80% sodium bicarbonate solution, 8% bovine serum albumin(BSA), 8% casein with
And 4% polyoxy alkene bay ether mixed liquid dipping, then dry.
(5) prepared by detection line：
1 plant of anti-human H-FABP monoclonal antibodies BT01 is taken to do detection line antibody, with buffer solution (10% trehalose, 6% first
Alcohol) it is diluted to 1mg/mL；Antibody is drawn on nitrocellulose filter with film instrument is drawn, a concentration of 1ul/cm forms detection line, vacuum
It is dry.
(6) prepared by nature controlling line：
Sheep anti-mouse igg is diluted to 0.5mg/mL with buffer solution (10% trehalose, 6% methanol)；Antibody is drawn with film instrument is drawn
On nitrocellulose filter, a concentration of 0.5ul/cm forms nature controlling line, vacuum drying.
(7) test strips are assembled：
Sample pad 1, gold-labelled pad 2, nitrocellulose filter 3 and blotting paper 4 are pasted onto to the plastics of single side pressure sensitive adhesive in order
On plate, as shown in Figure 1, being equipped with detection line antibody 5 and nature controlling line antibody 6 on nitrocellulose filter 3；6cm width is cut to paste
Plastic plate afterwards is packed into detection card；It is packed with the heat-sealing Fresco Bag with drier, room temperature preservation.
(8) it detects：
10000 μ l of sample are divided into 100 groups and are added dropwise to well respectively, when 15min is observed, interpretation ELISA test strip
As a result standard is：The positive has colour developing band at detection line and at nature controlling line；Feminine gender, without colour developing band, Quality Control at detection line
There is colour developing band at line；And developing sensitivity ＜ 3ng/mL, no broken string phenomenon.
The method of reference standard sample detection is detected 300 physical examination human normal plasma's samples, wherein 298 5 are divided
Clock i.e. detect as a result, and developing sensitivity ＜ 3ng/mL, no broken string phenomenon.
The above is only a preferred embodiment of the present invention, it should be pointed out that：For the ordinary skill people of the art
For member, various improvements and modifications may be made without departing from the principle of the present invention, these improvements and modifications are also answered
It is considered as protection scope of the present invention.
Claims (3)
1. a kind of H-FABP and cTnI bigeminy efficient detection test paper, it is characterised in that：It is sequentially connected in fixed plate including being located at
Sample pad (1), gold-labelled pad (2), nitrocellulose filter (3) and absorption pad (4)；Detection line is equipped on nitrocellulose filter (3)
Antibody (5) and nature controlling line antibody (6)；Gold labeling antibody is equipped in gold-labelled pad (2), the sample pad (1) is glass fibre cotton
Manufactured pad, the gold-labelled pad (2) are pad made of carboxylated cellulose film, and the gold labeling antibody is colour developing antibody, detection
Line antibody is to capture antibody, and colour developing antibody is 3 plants with capture antibody can mutually match to form sandwich anti-human H-FABP and cTnI
Gold labeling antibody described in monoclonal antibody is marked with 40nm nanometers of golden shells, and the gold-labelled pad is equipped with functional layer, the gold-labelled pad
Pass through sodium bicarbonate, bovine serum albumin(BSA), casein and polyoxy alkene bay ether mixed liquid dipping.
2. a kind of H-FABP and cTnI bigeminy efficient detection test paper according to claim 1, it is characterised in that：The function
Layer is made of 18% pure silver nitrate, 70% gelatin, 8% department's sheet 80 and 4% cyclodextrin based on mass fraction.
3. a kind of H-FABP and cTnI bigeminy efficient detection test paper according to claim 1, it is characterised in that：The gold mark
Pad is by 80% sodium bicarbonate solution, 8% bovine serum albumin(BSA), 8% casein and 4% polyoxy alkene bay ether mixed liquid dipping.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810225535.7A CN108445220A (en) | 2018-03-19 | 2018-03-19 | A kind of H-FABP and cTnI bigeminy efficient detection test paper |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810225535.7A CN108445220A (en) | 2018-03-19 | 2018-03-19 | A kind of H-FABP and cTnI bigeminy efficient detection test paper |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108445220A true CN108445220A (en) | 2018-08-24 |
Family
ID=63195815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810225535.7A Pending CN108445220A (en) | 2018-03-19 | 2018-03-19 | A kind of H-FABP and cTnI bigeminy efficient detection test paper |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108445220A (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996024060A1 (en) * | 1995-02-03 | 1996-08-08 | British Biocell International Limited | Assay device and method |
| US20050239145A1 (en) * | 2000-12-15 | 2005-10-27 | Albert Chu | Flow-through membrane assays for carbohydrates using labeled lectins |
| CN101806804A (en) * | 2010-01-08 | 2010-08-18 | 兰州生物制品研究所 | Reagent for detecting acute myocardial infarction by immunological method and test strip |
| CN102298055A (en) * | 2011-07-21 | 2011-12-28 | 南京博天科智生物技术有限公司 | Human blood H-FABP nano-gold labeled test paper and preparation method thereof |
| CN105339795A (en) * | 2014-02-27 | 2016-02-17 | 生物辐射实验室股份有限公司 | Lateral flow blotting assay |
| WO2017004463A1 (en) * | 2015-07-01 | 2017-01-05 | Abbott Laboratories | Devices and methods for sample analysis |
| WO2018022458A1 (en) * | 2016-07-25 | 2018-02-01 | Bio-Rad Laboratories, Inc. | Lateral flow device and method of use |
-
2018
- 2018-03-19 CN CN201810225535.7A patent/CN108445220A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996024060A1 (en) * | 1995-02-03 | 1996-08-08 | British Biocell International Limited | Assay device and method |
| US20050239145A1 (en) * | 2000-12-15 | 2005-10-27 | Albert Chu | Flow-through membrane assays for carbohydrates using labeled lectins |
| CN101806804A (en) * | 2010-01-08 | 2010-08-18 | 兰州生物制品研究所 | Reagent for detecting acute myocardial infarction by immunological method and test strip |
| CN102298055A (en) * | 2011-07-21 | 2011-12-28 | 南京博天科智生物技术有限公司 | Human blood H-FABP nano-gold labeled test paper and preparation method thereof |
| CN105339795A (en) * | 2014-02-27 | 2016-02-17 | 生物辐射实验室股份有限公司 | Lateral flow blotting assay |
| WO2017004463A1 (en) * | 2015-07-01 | 2017-01-05 | Abbott Laboratories | Devices and methods for sample analysis |
| WO2018022458A1 (en) * | 2016-07-25 | 2018-02-01 | Bio-Rad Laboratories, Inc. | Lateral flow device and method of use |
Non-Patent Citations (4)
| Title |
|---|
| KATIE A. EDWARDS等: "Liposome-Enhanced Lateral-Flow Assays for Clinical Analyses", 《METHODS IN MOLECULAR BIOLOGY》 * |
| LIQIANG LIU等: "Rapid detection of aldicarb in cucumber with an immunochromatographic test strip", 《FOOD AND AGRICULTURAL IMMUNOLOGY》 * |
| 刘慧: "金免疫层析法检测盐酸克伦特罗的工艺研究", 《中国优秀硕士学位论文全文数据库 医药卫生科技辑》 * |
| 明晓: "猪流感病毒胶体金检测方法的建立及应用", 《中国优秀硕士学位论文全文数据库 农业科技辑》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105588939B (en) | MPO, H FABP and cTnT joint-detections device and preparation method | |
| CN102298055B (en) | Human blood H-FABP nano-gold labeled test paper and preparation method thereof | |
| CN103901216B (en) | People H-FABP colloidal gold test and preparation method thereof | |
| CN111426844A (en) | Novel fluorescence immunochromatographic test strip for combined detection of coronavirus SARS-CoV-2 IgG-IgM antibody | |
| CN108088994A (en) | A kind of hollow core shell nanoparticles and preparation method, test strips and test method | |
| CN103048455B (en) | Herbicide 2, 4-D and pesticide CHI bigeminy detection card and preparation method thereof | |
| CN110456038A (en) | A kind of African swine fever virus antigen duplex detection reagent and preparation method thereof | |
| CN105572371A (en) | Immune colloidal gold detecting card of diclazuril and preparation method of immune colloidal gold detecting card | |
| CN110244062A (en) | A kind of excrement calprotectin or lactoferrin combined detection reagent and preparation method thereof | |
| CN105785028A (en) | Rapid diagnosis kit for detecting novel human cardiac failure marker ST2 | |
| CN107315091A (en) | One kind detection Cistofuran metabolite quantum dot immune chromatographic test paper, preparation method and applications | |
| CN107942052B (en) | A kind of colloidal gold kit and preparation method thereof detecting beta-stimulants | |
| CN206258465U (en) | A kind of fast joint detects the test paper of hepatitis C virus antigen-antibody | |
| CN108445220A (en) | A kind of H-FABP and cTnI bigeminy efficient detection test paper | |
| CN108956992A (en) | A kind of preparation method of the Ribavirin test strip based on quantum dot fluorescence | |
| CN108445229A (en) | A kind of preparation method of H-FABP and cTnI bigeminy efficient detection test paper | |
| CN104730248A (en) | Rapid diagnosis and detection test paper card for detecting swine fever as well as preparation and application method of rapid diagnosis and detection test paper card | |
| CN107015006A (en) | A kind of cell factor immune chromatography test paper and preparation method thereof | |
| CN107356740A (en) | A kind of aptamer of cortisol and the gold label test strip for detecting cortisol | |
| CN109212203A (en) | A kind of quantum dot immune chromatograph test strip of quick detection Brucella antibody | |
| CN109444400A (en) | A kind of Sidestream chromatography test paper and its preparation method and application | |
| CN109085353A (en) | A kind of Candida albicans colloidal-gold detecting-card and its application | |
| CN108226514A (en) | A kind of newcastle disease virus antibody rapid quantitative detection reagent box and its application | |
| CN111638363B (en) | 3-deoxyfructose rapid quantitative fluorescence detection device and preparation method thereof | |
| CN106932592A (en) | Detect colloidal gold strip of people's surfactant protein A and its preparation method and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180824 |
|
| RJ01 | Rejection of invention patent application after publication |